Randy Reese
Family Medicine · Eugene, ORNPI 1568488583
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 318 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,128 and has fallen 93.5% since, to $139 in 2022. Among family medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amarin Pharma, Inc.$699
- Pfizer$630
- AbbVie$550
- Amgen$395
- Lilly USA, LLC$394
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,31099%
- Education$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $1,120 |
| Amarin Pharma, Inc. | 45 | $699 |
| Pfizer | 41 | $630 |
| AbbVie(2 entities) | 42 | $550 |
| Amgen | 25 | $395 |
| Lilly USA, LLC | 25 | $394 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $227 |
| Novo Nordisk | 10 | $178 |
| Indivior Inc. | 10 | $162 |
| Teva Pharmaceuticals USA, Inc. | 8 | $159 |
| Johnson & Johnson | 8 | $123 |
| GSK | 7 | $110 |
| Merck | 6 | $104 |
| Eisai Inc. | 5 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Boehringer Ingelheim | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Bayer | 2 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| GRT US Holding, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$120
How this compares
$5,384 in reported general payments places this provider in the 95th percentile of 1,221 family medicine providers in Oregon.
Other family medicine in Eugene
- Hylke SniederEugene$6K
- David KobliskaEugene$4K
- Eden MillerBend$1.7M
- Anil RajaniHood River$325K
- Stephen NelsonMedford$101K
- Karen KahnAshland$86K
- Robert GobboPortland$53K
- Kevin MillerSisters$39K
- Morris MaizelsCentral Point$25K
- Maureen MaysPortland$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.